Printer Friendly

SALVATORI OPHTHALMICS TALKS CONTINUING FOR ACQUISITION OF G.T. LABORATORIES AND FUSED KONTACTS, INC.

 SALVATORI OPHTHALMICS TALKS CONTINUING FOR ACQUISITION
 OF G.T. LABORATORIES AND FUSED KONTACTS, INC.
 SARASOTA, Fla., Sept. 15 /PRNewswire/ -- Salvatori Ophthalmics, Inc. announced today that it has entered into an agreement extending its exclusive right to acquire G.T. Laboratories and Fused Kontacts, Inc., privately owned manufacturers of rigid gas permeable contact lenses and materials, until Nov. 30, 1992.
 Salvatori is a manufacturer of specialty contact lenses, including rigid gas permeable and soft contact lenses for daily and extended wear, sold to eye care professionals. The company has manufacturing facilities located at Sarasota, Fla., and Lincoln, Neb. and is headquartered in Sarasota. Salvatori Ophthalmics' stock is quoted by the National Association of Securities Dealers under the symbol EYES.
 G.T. Laboratories/Fused Kontacts is a private company which manufactures a line of blanks, sold under the Flourex and Sil-O-Flex brand names, from which gas permeable contact lenses are manufactured. In addition, Fused Kontacts manufactures a line of contact lenses, principal among them the Tangent Streak line of rigid gas permeable bifocal and trifocal lenses. Closing of the transaction is subject the completion of due diligence by the buyer and the completion of financing arrangements.
 -0- 9/15/92
 /CONTACT: David J. Dougherty of Salvatori Ophthalmics, 813-753-0383/ CO: Salvatori Ophthalmics ST: Florida IN: MTC SU: TNM


JB-JJ -- FL005 -- 9566 09/15/92 11:04 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 15, 1992
Words:224
Previous Article:GRAND METROPOLITAN PROPOSES U.S. DEBT ISSUE OF $600 MILLION AND UPDATES 1992 TRADING OUTLOOK
Next Article:HEALTH COMMUNICATION SERVICES CHOSEN TO CREATE NATIONAL MODEL FOR ELECTRONIC DATA INTERCHANGE IN HEALTHCARE
Topics:


Related Articles
SALVATORI OPHTHALMICS COMPLETES $700,000 FINANCING WITH TULLIS-DICKERSON CAPITAL FOCUS, L.P.
SALVATORI OPHTHALMICS REPORTS 1991 THIRD QUARTER RESULTS OF OPERATIONS
SALVATORI OPHTHALMICS, INC. ANNOUNCES PROPOSED ACQUISITION OF G.T. LABORATORIES, INC. AND FUSED KONTACTS, INC.
SALVATORI OPHTHALMICS MAKES ANNOUNCEMENT REGARDING COMMON STOCK
SALVATORI OPHTHALMICS, INC. AND G.T. LABORATORIES, INC./FUSED KONTACTS INC. ANNOUNCE AGREEMENT TO END ACQUISITION TALKS
SALVATORI OPHTHALMICS ANNOUNCES APPOINTMENT OF JOSEPH A. ARENA AS CHIEF EXECUTIVE OFFICER
AMERICAN CONSOLIDATED LABORATORIES, INC. ANNOUNCES PLANS TO ACQUIRE CAROLINA CONTACT LENS, INC.
AMERICAN CONSOLIDATED LABORATORIES, INC. TO ACQUIRE MID-SOUTH CONTACT LENS, INC.
American Consolidated Laboratories, Inc. Announces Acquisition Of NovaVision, Inc. And New Financing Agreement
American Consolidated Laboratories, Inc. Announces Acquisition of Worthington Group

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters